Nm23 expression in breast ductal carcinomas: A ten year follow-up study in a uniform group of node-negative breast cancer patients

Anticancer Research

Volumn 16, Issue 6 C, 1996, Pages 3987-3990

  Kapranos, Nikiforos ^a,c   Karaiossifidi, Helen ^b   Kouri, Efi ^b   Vasilaros, Stamatis ^b  

^a HYGEIA HOSPITAL   (Greece)

^b HELENA VENIZELOU HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

Breast cancer; Immunohistochemistry; Metastasis; Nm23; Node negative; Prognostic factors

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN P53;

ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MELANOMA CELL; METASTASIS POTENTIAL; MORTALITY; PRIORITY JOURNAL; RELAPSE; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030519427     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Spyratos F, Martin PM, Hacene K, Romain S, Andrieu C, Ferero-Pouo, Deytieux S, Doussal V, Tubiana-Hulin, Brunet M: Multiparametric prognostic evaluation of biological factors in primary breast cancer. J Natl Cancer Inst 84: 1266-1272, 1992.
2. Wong WW, Vijayakumar S: Prognostic indicators in node-negative early stage breast cancer. Am J Med 92: 539-548, 1992.
3. Valagussa P, Bonnadona G, Veronesi U: Patterns of relapse and survival following radical mastectomy. Cancer 41: 1170-1178, 1978.
4. Fisher B, Redmond C, Fisher ER, Caplan R: Relative worth of estrogen or progesterone receptor and pathologic characteristic of differentiation as indicators of prognosis in node negative breast cancer patients: Findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol 6: 1076-1087, 1989.
5. Thorpe SM, Rose C, Rasmussen BB, Mouridsen HT, Bayer T, Keiding N: Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node-negative breast cancer. Cancer Res 47: 6126-6133, 1987.
6. Caligo MA, Cipollini G, Fiore L, Calvo S, Basolo F, Collecchi P, Ciardello F, Pere S, Petrini M, Bevilacqua G: NM23 gene expression correlates with cell growth rate and S-phase. Int J Cancer 60: 837-842, 1995.
7. Howlett AR, Petersen OW, Steeg PS, Bissel MJ: A novel function for the nm23-H1 gene: Overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J Natl Cancer Inst 86: 1838-1844, 1994.
8. Hirayama R, Sawai S, Takagi Y, Mishima Y, Narishimi K, Shimada N, Esaki Y, Kurashima C, Masanori U, Hirokawa K: Positive relationship between expression of anti-metastatic factor (nm23 gene product or Nucleoside Diphosphate Kinase) and good prognosis in human breast cancer. J Natl Cancer Inst 83: 1249-1250, 1991.
9. Sastre-Garau X, Lacombe ML, Jouve M, Veron M, Magdelenat H: Nucleoside diphosphate kinase/nm23 expression in breast cancer: Lack of correlation with lymph-node metastasis. Int J Cancer 50: 533-538, 1992.
10. Tokunaga Y, Urano T, Furukawa K, Kondo H, Kanematsu T, Shiku H: Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int J Cancer 55: 66-71, 1993.